TrialInternational journal of hematology2026

Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study.

Yoshinobu Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.